We believe in – and have seen firsthand many times over – the power of innovation to positively transform health and well-being. That’s why we actively support research and development into scientific breakthroughs that can help solve the world’s most challenging problems.
Trevor Mundel, who leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries, discusses the first trials funded through the Therapeutics…
Interview with Trevor Mundel on COVID-19. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The…
Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team.
In Burkina Faso, the seasonal “Harmattan” winds have traditionally been associated with deadly meningitis outbreaks. But the winds have changed. A historic partnership between Burkina Faso and Gavi, the Vaccine…
